Nicotine
NDC Package 64725-5895-1
Package Information
Nicotine is if you are under 18 years of age, ask a doctor before useBefore using this product, read the enclosed self-help guide for complete directions and other informationStop smoking completely when you begin using the patchIf you smoke more than 10 cigarettes per day, use the following schedule:Weeks 1 thru 4Weeks 5 and 6Weeks 7 and 8STEP 1STEP 2STEP 3use one 21 mg patch/dayuse one 14 mg patch/dayuse one 7 mg patch/dayIf you smoke 10 or start with for 6 weeks, then for 2 weeks and then stop less cigarettes per day,Step 2Step 3Apply one new patch every 24 hours on skin that is dry, clean, and hairlessRemove backing from patch and immediately press onto skin. Marketed by Tya Pharmaceuticals, this product is identified by NDC 64725-5895 and is authorized under FDA application ANDA074612.
Identification & Billing
- RxCUI: 198029 - nicotine 14 MG/Day 24HR Transdermal System
- RxCUI: 198029 - 24 HR nicotine 0.583 MG/HR Transdermal System
- RxCUI: 198029 - nicotine 0.583 MG/HR 24HR Transdermal Patch
- RxCUI: 198029 - nicotine 14 MG per 24HR 1 Day Transdermal Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64725 - Tya Pharmaceuticals
- 64725-5895 - Nicotine
- 64725-5895-1 - 14 h in 1 BOX
- 64725-5895 - Nicotine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64725-5895-1 identifies a specific commercial package of 14 h in 1 box of Nicotine, labeled by Tya Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tya Pharmaceuticals on October 20, 1997. The current certification is valid through December 31, 2017.
How is this Tya Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64725589501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.